Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Cardiovascular profile of loratadine
Autore:
Hey, JA; Affrime, M; Cobert, B; Kreutner, W; Cuss, FM;
Indirizzi:
Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA Schering Plough Corp Kenilworth NJ USA 07033 st, Kenilworth, NJ 07033 USA
Titolo Testata:
CLINICAL AND EXPERIMENTAL ALLERGY
, volume: 29, anno: 1999, supplemento:, 3
pagine: 197 - 199
SICI:
0954-7894(199907)29:<197:CPOL>2.0.ZU;2-P
Fonte:
ISI
Lingua:
ENG
Soggetto:
2ND-GENERATION ANTIHISTAMINES; MOLECULAR-BASIS; TERFENADINE; HERG; CARDIOTOXICITY; ANTAGONISTS; ASTEMIZOLE; CHANNELS;
Keywords:
loratadine; non-sedating antihistamine; cardiovascular;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
16
Recensione:
Indirizzi per estratti:
Indirizzo: Cuss, FM Schering Plough Corp, Res Inst, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA Schering Plough Corp 2015 Galloping Hill Rd Kenilworth NJ USA 07033
Citazione:
J.A. Hey et al., "Cardiovascular profile of loratadine", CLIN EXP AL, 29, 1999, pp. 197-199

Abstract

The extremely low reporting rate of cardiovascular adverse events for loratadine, the possible preferential use of loratadine in patients with pre-existing cardiovascular disorders, and the impressive lack of cardiovascular effects at extremely high concentrations in clinical and preclinical studies demonstrate the very safe cardiovascular profile of loratadine.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/09/18 alle ore 08:26:45